MENU
+Compare
LYRA
Stock ticker: NASDAQ
AS OF
Jul 18, 01:44 PM (EDT)
Price
$8.22
Change
-$0.31 (-3.63%)
Capitalization
13.67M

LYRA Lyra Therapeutics Inc Forecast, Technical & Fundamental Analysis

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients... Show more

LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LYRA with price predictions
Jul 17, 2025

LYRA sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for LYRA moved above the 200-day moving average on July 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LYRA advanced for three days, in of 235 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

LYRA moved below its 50-day moving average on July 03, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LYRA crossed bearishly below the 50-day moving average on July 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LYRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LYRA entered a downward trend on July 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.530) is normal, around the industry mean (17.995). P/E Ratio (0.000) is within average values for comparable stocks, (59.169). LYRA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.515). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (9.461) is also within normal values, averaging (275.695).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LYRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LYRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LYRA is expected to report earnings to rise 26.92% to -16 cents per share on August 12

Lyra Therapeutics Inc LYRA Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.41
The last earnings report on May 06 showed earnings per share of -12 cents, missing the estimate of -11 cents. With 10.45K shares outstanding, the current market capitalization sits at 13.67M.
A.I. Advisor
published General Information

General Information

a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 393-4600
Employees
145
Web
https://lyratherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACXP0.450.02
+4.27%
Acurx Pharmaceuticals
EYPT10.300.24
+2.39%
EyePoint Pharmaceuticals
APTV70.270.14
+0.20%
Aptiv PLC
BMA65.50-0.75
-1.13%
Banco Macro SA
MIST1.65-0.02
-1.20%
Milestone Pharmaceuticals

LYRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been loosely correlated with EYPT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if LYRA jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+0.23%
EYPT - LYRA
58%
Loosely correlated
+2.39%
VERA - LYRA
54%
Loosely correlated
+0.85%
KYMR - LYRA
53%
Loosely correlated
+1.85%
BPMC - LYRA
42%
Loosely correlated
+0.14%
CLNN - LYRA
39%
Loosely correlated
+3.45%
More

Groups containing LYRA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+0.23%
LYRA
(1 stocks)
42%
Loosely correlated
-3.68%